Biomarkers immunogenic cancer antigens antigen of tumor. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy18

Cell Line, Tumor Peritoneum T-Lymphocytes Cell Line Tumor Cells, Cultured Cells, Cultured B-Lymphocytes Immune Sera Spleen Dendritic Cells Lymph Nodes Lymphocytes CD8-Positive T-Lymphocytes CD4-Positive T-Lymphocytes Neoplastic Stem Cells Clone Cells Antigen-Presenting Cells T-Lymphocytes, Cytotoxic

Organisms8

Mice, Inbred BALB C Mice, Inbred C57BL Mice, Nude Mice, Transgenic Mice, SCID Mice, Inbred Strains Simian virus 40 Rabbits

Diseases42

Ovarian Neoplasms Neoplasms Prostatic Neoplasms Neoplasm Metastasis Breast Neoplasms Adenocarcinoma Krukenberg Tumor Lung Neoplasms Colonic Neoplasms Neoplasms, Experimental Pancreatic Neoplasms Disease Progression Stomach Neoplasms Wilms Tumor Cell Transformation, Neoplastic Carcinoma, Squamous Cell Mammary Neoplasms, Experimental Brain Neoplasms Neovascularization, Pathologic Liver Neoplasms Carcinoid Tumor Urinary Bladder Neoplasms Neoplasm Recurrence, Local Disease Models, Animal Skin Neoplasms Neuroendocrine Tumors Kidney Neoplasms Neoplasm Invasiveness Genetic Predisposition to Disease Uterine Cervical Neoplasms Carcinoma, Non-Small-Cell Lung Bone Neoplasms Rectal Neoplasms Colorectal Neoplasms Gastrointestinal Neoplasms Lymphoma Melanoma, Experimental Carcinoma, Hepatocellular Head and Neck Neoplasms Fibrosarcoma Sarcoma, Experimental Esophageal Neoplasms

Chemicals and Drugs98

CA-125 Antigen Antigens, Neoplasm Antigens Antigens, Bacterial Tumor Markers, Biological Antigens, Surface Antigens, Tumor-Associated, Carbohydrate Carcinoembryonic Antigen Antigens, Viral Mucin-1 Antibodies, Monoclonal Cancer Vaccines Antigens, Polyomavirus Transforming Antigens, Protozoan CA-19-9 Antigen Biological Markers HLA Antigens Dialysis Solutions Antigens, CD Neoplasm Proteins Antigens, Fungal Antigens, Helminth Epitopes H-2 Antigens Antigens, Viral, Tumor Prostate-Specific Antigen Tumor Necrosis Factor-alpha RNA, Messenger Proliferating Cell Nuclear Antigen Antibodies, Neoplasm Receptors, Antigen, T-Cell HLA-DR Antigens Histocompatibility Antigens Histocompatibility Antigens Class II Tumor Suppressor Protein p53 GPI-Linked Proteins Receptors, Antigen, B-Cell O Antigens HLA-A2 Antigen Antigens, CD15 Immunoglobulin G Membrane Proteins Antigens, CD8 Antigens, CD3 HLA-A Antigens Tumor Suppressor Proteins Histocompatibility Antigens Class I Blood Group Antigens Hepatitis B Surface Antigens Ki-67 Antigen Antigens, CD45 HLA-D Antigens Receptors, Antigen DNA, Neoplasm Antineoplastic Agents Antigens, CD4 Hepatitis B Antigens Antigens, Differentiation Antibodies Antigens, CD1 Antibodies, Bacterial Recombinant Proteins MART-1 Antigen Immune Sera HLA-B Antigens Antigens, CD80 Interferon-gamma Peptides Receptors, Estrogen Cytokines Glycoproteins HIV Antigens Autoantigens Antigens, CD19 Antigens, CD40 Epstein-Barr Virus Nuclear Antigens RNA, Small Interfering DNA-Binding Proteins Antigens, Heterophile Biomarkers, Pharmacological Antigen-Antibody Complex Immunoglobulin M Antigens, Thy-1 Hepatitis B Core Antigens DNA Primers Peptide Fragments Carcinogens MicroRNAs Forssman Antigen RNA, Neoplasm Recombinant Fusion Proteins Ovalbumin Antigens, CD95 Antigens, CD86 Proto-Oncogene Proteins Autoantibodies H-Y Antigen CTLA-4 Antigen

Analytical, Diagnostic and Therapeutic Techniques and Equipment52

Enzyme-Linked Immunosorbent Assay Sensitivity and Specificity Immunoenzyme Techniques Prognosis Tumor Burden Neoplasm Staging Immunohistochemistry Early Detection of Cancer Neoplasms, Experimental Immunotherapy ROC Curve Prospective Studies Reverse Transcriptase Polymerase Chain Reaction Blotting, Western Flow Cytometry Gene Expression Profiling Fluorescent Antibody Technique Lymphocyte Activation Transplantation, Heterologous Xenograft Model Antitumor Assays Mammary Neoplasms, Experimental Polymerase Chain Reaction Survival Analysis Peritoneal Dialysis Transfection Retrospective Studies Neoplasm Transplantation Survival Rate Immunization Predictive Value of Tests Disease Models, Animal Follow-Up Studies Reproducibility of Results Treatment Outcome Oligonucleotide Array Sequence Analysis Antineoplastic Combined Chemotherapy Protocols Combined Modality Therapy Peritoneal Dialysis, Continuous Ambulatory Disease-Free Survival Immunoassay Immunoblotting Risk Factors Models, Biological Risk Assessment Immunodiffusion Kaplan-Meier Estimate Melanoma, Experimental Risk Multivariate Analysis Sarcoma, Experimental Protein Array Analysis Complement Fixation Tests

Phenomena and Processes41

Sensitivity and Specificity Amino Acid Sequence Genes, Tumor Suppressor Gene Expression Regulation, Neoplastic Base Sequence Cell Division Mutation Lymphocyte Activation Cross Reactions Cell Proliferation Time Factors Antibody Specificity Tumor Microenvironment Transfection Signal Transduction Antigen-Antibody Reactions Antibody Formation Phenotype Gene Expression Cell Survival Cell Movement Dose-Response Relationship, Drug Down-Regulation Cytotoxicity, Immunologic Genetic Predisposition to Disease Apoptosis DNA Methylation Up-Regulation Promoter Regions, Genetic Molecular Weight Immunity, Cellular Cell Cycle Cell Differentiation Genotype Genetic Vectors Risk Protein Binding Tissue Distribution Cell Growth Processes Phosphorylation Genes, p53

Disciplines and Occupations2

Immunohistochemistry Proteomics

Information Science4

Molecular Sequence Data Amino Acid Sequence Base Sequence Survival Rate

Health Care19

Sensitivity and Specificity ROC Curve Prospective Studies Survival Analysis Retrospective Studies Survival Rate Immunization Predictive Value of Tests Follow-Up Studies Reproducibility of Results Treatment Outcome Peritoneal Dialysis, Continuous Ambulatory Disease-Free Survival Risk Factors Risk Assessment Kaplan-Meier Estimate Age Factors Risk Multivariate Analysis

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Information Science Health Care

CA-125 Antigen Antigens, Neoplasm Antigens Antigens, Bacterial Tumor Markers, Biological Antigens, Surface Antigens, Tumor-Associated, Carbohydrate Carcinoembryonic Antigen Antigens, Viral Ovarian Neoplasms Mucin-1 Antibodies, Monoclonal Cancer Vaccines Antigens, Polyomavirus Transforming Antigens, Protozoan Cell Line, Tumor CA-19-9 Antigen Neoplasms Biological Markers Enzyme-Linked Immunosorbent Assay HLA Antigens Prostatic Neoplasms Neoplasm Metastasis Breast Neoplasms Dialysis Solutions Antigens, CD Neoplasm Proteins Sensitivity and Specificity Antigens, Fungal Antigens, Helminth Immunoenzyme Techniques Epitopes H-2 Antigens Antigens, Viral, Tumor Molecular Sequence Data Peritoneum Adenocarcinoma Krukenberg Tumor Prostate-Specific Antigen Lung Neoplasms Prognosis Tumor Burden Mice, Inbred BALB C Tumor Necrosis Factor-alpha Neoplasm Staging RNA, Messenger Proliferating Cell Nuclear Antigen Antibodies, Neoplasm Immunohistochemistry Receptors, Antigen, T-Cell HLA-DR Antigens Colonic Neoplasms Amino Acid Sequence Early Detection of Cancer Histocompatibility Antigens T-Lymphocytes Neoplasms, Experimental Cell Line Histocompatibility Antigens Class II Tumor Suppressor Protein p53 GPI-Linked Proteins Receptors, Antigen, B-Cell Immunotherapy O Antigens Mice, Inbred C57BL HLA-A2 Antigen ROC Curve Antigens, CD15 Genes, Tumor Suppressor Prospective Studies Immunoglobulin G Mice, Nude Gene Expression Regulation, Neoplastic Reverse Transcriptase Polymerase Chain Reaction Membrane Proteins Antigens, CD8 Pancreatic Neoplasms Disease Progression Blotting, Western Flow Cytometry Base Sequence Gene Expression Profiling Antigens, CD3 Cell Division Fluorescent Antibody Technique Mutation Stomach Neoplasms Lymphocyte Activation Cross Reactions HLA-A Antigens Tumor Suppressor Proteins Cell Proliferation Transplantation, Heterologous Xenograft Model Antitumor Assays Histocompatibility Antigens Class I Time Factors Blood Group Antigens Wilms Tumor Cell Transformation, Neoplastic Antibody Specificity

No FAQ available that match "biomarkers immunogenic cancer antigens antigen of tumor"